This 30-minute educational webinar is designed for health care providers and stakeholders seeking to optimize biomarker testing strategies in breast cancer within the community oncology setting. The session provides a comprehensive overview of when and how to utilize tissue and/or liquid biopsy specimens across the breast cancer care continuum. Topics include the clinical relevance of actionable biomarkers, the comparative utility of comprehensive molecular profiling versus single-gene testing, and the role of circulating tumor DNA (ctDNA) in guiding treatment decisions.

Participants will also gain insights into the practical considerations of biopsy selection, including tissue insufficiency, clonal hematopoiesis, and the benefits of concurrent testing. The webinar concludes with a focused discussion on payer coverage and reimbursement policies, equipping health care providers with the knowledge to navigate the financial aspects of biomarker testing.